Cargando…

Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system

Vascular endothelial growth factor (VEGF) reportedly has an important role in the progression of malignant neoplasms and has been reported to induce myeloid-derived suppressor cells (MDSCs) that appear in cancer and inflammation. In the present study, serum concentrations of VEGF were measured in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	NAKAMURA, IZUMI, SHIBATA, MASAHIKO, GONDA, KENJI, YAZAWA, TAKASHI, SHIMURA, TATSUO, ANAZAWA, TAKAYUKI, SUZUKI, SATOSHI, SAKURAI, KENICHI, KOYAMA, YOSHIHISA, OHTO, HITOSHI, TOMITA, RYOUICHI, GOTOH, MITSUKAZU, TAKENOSHITA, SEIICHI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678612/ https://www.ncbi.nlm.nih.gov/pubmed/23761834 http://dx.doi.org/10.3892/ol.2013.1231

Ejemplares similares

Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers
por: YAZAWA, TAKASHI, et al.
Publicado: (2013)

Serum Soluble Interleukin-2 Receptor is Increased in Malnourished and Immunosuppressed Patients With Gastric and Colorectal Cancer: Possible Influence of Myeloid-Derived Suppressor Cells
por: Gonda, Kenji, et al.
Publicado: (2012)

The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
por: Yang, Fan, et al.
Publicado: (2018)

Intranuclear accumulation of galectin-3 is an independent prognostic factor for patients with distal cholangiocarcinoma
por: Shimura, Tatsuo, et al.
Publicado: (2017)

Concomitant existence of pheochromocytoma in a patient with multiple endocrine neoplasia type 1
por: Okada, Ryo, et al.
Publicado: (2016)

Serum levels of rapid turnover proteins are decreased and related to systemic inflammation in patients with ovarian cancer
por: WATANABE, TAKAFUMI, et al.
Publicado: (2014)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
por: Xue, Yaxian, et al.
Publicado: (2019)

Immunosuppressive MDSCs induced by TLR signaling during infection and role in resolution of inflammation
por: Ray, Anuradha, et al.
Publicado: (2013)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Correction to: Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
por: Xue, Yaxian, et al.
Publicado: (2022)

Activation of VIP signaling enhances immunosuppressive effect of MDSCs on CMV-induced adaptive immunity
por: Forghani, Parvin, et al.
Publicado: (2017)

A case of lipoma, calcification, and brain malformations in the midline of the skull
por: Kanazawa, Hideto, et al.
Publicado: (2021)

Comprehensive analysis of gene expression of isolated pancreatic islets during pretransplant culture
por: Haga, Junichiro, et al.
Publicado: (2021)

Acinar Cell Cystadenocarcinoma of the Pancreas
por: Aoto, Keita, et al.
Publicado: (2017)

New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs
por: Lakshmanachetty, Senthilnath, et al.
Publicado: (2021)

Renal cancer-derived exosomes induce tumor immune tolerance by MDSCs-mediated antigen-specific immunosuppression
por: Gao, Yingying, et al.
Publicado: (2020)

IM-1 THE IMMUNOSUPPRESSIVE ROLE OF MAIT CELLS AND MR1 IN GBM THROUGH THE INDUCTION OF NEUTROPHILS AND MDSCS
por: Hana, Taijun, et al.
Publicado: (2022)

ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
por: Chen, Huanhuan, et al.
Publicado: (2023)

Clinical relevance of systemic monocytic-MDSCs in patients with metastatic breast cancer
por: Bergenfelz, Caroline, et al.
Publicado: (2020)

Ficus pumila L. improves the prognosis of patients infected with HTLV-1, an RNA virus
por: Gonda, Kenji, et al.
Publicado: (2021)

Soluble interleukin-2 receptor as a predictive and prognostic marker for patients with familial breast cancer
por: Gonda, Kenji, et al.
Publicado: (2021)

Risk Models of Operative Morbidities in 16,930 Critically Ill Surgical Patients Based on a Japanese Nationwide Database
por: Saze, Zenichiro, et al.
Publicado: (2015)

Comparison of National Operative Mortality in Gastroenterological Surgery Using Web-based Prospective Data Entry Systems
por: Anazawa, Takayuki, et al.
Publicado: (2015)

Ex vivo Pretreatment of Islets with Mitomycin C: Reduction in Immunogenic Potential of Islets by Suppressing Secretion of Multiple Chemotactic Factors
por: Sato, Naoya, et al.
Publicado: (2017)

Primary Adenocarcinoma of the Minor Duodenal Papilla
por: Wakatsuki, Takeru, et al.
Publicado: (2008)

Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer
por: Okła, Karolina, et al.
Publicado: (2019)

A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment
por: Hofer, Francesca, et al.
Publicado: (2021)

The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype
por: Sun, Yingying, et al.
Publicado: (2022)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration
por: Ding, Lijuan, et al.
Publicado: (2023)

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients
por: Bergenfelz, Caroline, et al.
Publicado: (2015)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

Myeloid Derived Suppressor Cells (MDSCs) Are Increased and Exert Immunosuppressive Activity Together with Polymorphonuclear Leukocytes (PMNs) in Chronic Myeloid Leukemia Patients
por: Giallongo, Cesarina, et al.
Publicado: (2014)

Catechins and antitumor immunity: Not MDSC’s cup of tea
por: Santilli, Giorgia, et al.
Publicado: (2013)

Improving cancer immunotherapy by targeting the STATe of MDSCs
por: de Haas, Nienke, et al.
Publicado: (2016)

Connections between Metabolism and Epigenetic Modification in MDSCs
por: Dai, Haiyan, et al.
Publicado: (2020)

The Engagement Between MDSCs and Metastases: Partners in Crime
por: Trovato, Rosalinda, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells (MDSCs) in Haematology
por: Bizymi, Nikoleta, et al.
Publicado: (2021)

The Function and Therapeutic Implications of TNF Signaling in MDSCs
por: Yu, Kun, et al.
Publicado: (2022)

Mesenchymal stem cells, as glioma exosomal immunosuppressive signal multipliers, enhance MDSCs immunosuppressive activity through the miR-21/SP1/DNMT1 positive feedback loop
por: Qiu, Wei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mirpgss6kd63tqs19bngesuupr